Compare Wockhardt with Cadila Healthcare - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

WOCKHARDT vs CADILA HEALTHCARE - Comparison Results

WOCKHARDT     Change

Wockhardt is one of the leading domestic pharmaceutical companies with strong presence in the lifestyle segment and a growing focus on biotechnology. While the company made a string of acquisitions in the past namely 'Esparma GmbH' in Germany, 'Pinew... More

CADILA HEALTHCARE 
   Change

Cadila Healthcare is one of the leading players in the Indian pharma market having a presence in both the domestic and international markets. In the international markets, the company had adopted the strategy of competing directly in the generics mar... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    WOCKHARDT CADILA HEALTHCARE WOCKHARDT/
CADILA HEALTHCARE
 
P/E (TTM) x -48.0 30.2 - View Chart
P/BV x 1.1 3.6 29.4% View Chart
Dividend Yield % 0.0 1.0 0.4%  

Financials

 WOCKHARDT   CADILA HEALTHCARE
EQUITY SHARE DATA
    WOCKHARDT
Mar-18
CADILA HEALTHCARE
Mar-19
WOCKHARDT/
CADILA HEALTHCARE
5-Yr Chart
Click to enlarge
High Rs1,012432 234.0%   
Low Rs532306 173.5%   
Sales per share (Unadj.) Rs355.9128.6 276.7%  
Earnings per share (Unadj.) Rs-60.318.5 -325.0%  
Cash flow per share (Unadj.) Rs-46.824.4 -191.7%  
Dividends per share (Unadj.) Rs0.013.50 0.3%  
Dividend yield (eoy) %00.9 0.1%  
Book value per share (Unadj.) Rs257.8101.5 254.1%  
Shares outstanding (eoy) m110.631,023.74 10.8%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x2.22.9 75.5%   
Avg P/E ratio x-12.819.9 -64.3%  
P/CF ratio (eoy) x-16.515.1 -109.0%  
Price / Book Value ratio x3.03.6 82.2%  
Dividend payout %018.9 -0.1%   
Avg Mkt Cap Rs m85,379378,170 22.6%   
No. of employees `0006.312.4 50.3%   
Total wages/salary Rs m9,37121,241 44.1%   
Avg. sales/employee Rs Th6,295.010,585.0 59.5%   
Avg. wages/employee Rs Th1,498.31,707.8 87.7%   
Avg. net profit/employee Rs Th-1,066.31,526.5 -69.8%   
INCOME DATA
Net Sales Rs m39,369131,656 29.9%  
Other income Rs m1,2022,011 59.8%   
Total revenues Rs m40,571133,667 30.4%   
Gross profit Rs m1829,731 0.1%  
Depreciation Rs m1,4955,986 25.0%   
Interest Rs m2,5551,935 132.0%   
Profit before tax Rs m-2,83023,821 -11.9%   
Minority Interest Rs m0469 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m-3,5820-   
Tax Rs m2575,303 4.8%   
Profit after tax Rs m-6,66918,987 -35.1%  
Gross profit margin %022.6 0.2%  
Effective tax rate %-9.122.3 -40.8%   
Net profit margin %-16.914.4 -117.5%  
BALANCE SHEET DATA
Current assets Rs m33,79684,981 39.8%   
Current liabilities Rs m26,91773,425 36.7%   
Net working cap to sales %17.58.8 199.1%  
Current ratio x1.31.2 108.5%  
Inventory Days Days7975 106.5%  
Debtors Days Days89110 81.5%  
Net fixed assets Rs m39,664133,493 29.7%   
Share capital Rs m5531,024 54.0%   
"Free" reserves Rs m27,968102,839 27.2%   
Net worth Rs m28,522103,863 27.5%   
Long term debt Rs m21,73139,497 55.0%   
Total assets Rs m81,620234,831 34.8%  
Interest coverage x-0.113.3 -0.8%   
Debt to equity ratio x0.80.4 200.4%  
Sales to assets ratio x0.50.6 86.0%   
Return on assets %-5.08.9 -56.6%  
Return on equity %-23.418.3 -127.9%  
Return on capital %-7.718.3 -42.0%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m9,80748,404 20.3%   
Fx outflow Rs m1,78911,593 15.4%   
Net fx Rs m8,01936,811 21.8%   
CASH FLOW
From Operations Rs m68428,823 2.4%  
From Investments Rs m6,302-57,387 -11.0%  
From Financial Activity Rs m-7,69518,846 -40.8%  
Net Cashflow Rs m-664-7,105 9.3%  

Share Holding

Indian Promoters % 74.5 74.8 99.6%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 2.3 8.3 27.7%  
FIIs % 7.7 5.9 130.5%  
ADR/GDR % 0.1 0.0 -  
Free float % 15.4 11.0 140.0%  
Shareholders   67,757 44,069 153.8%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare WOCKHARDT With:   SUN PHARMA  PROCTER & GAMBLE HEALTH  NOVARTIS  UNICHEM LAB  DR. REDDYS LAB  

Compare WOCKHARDT With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends 178 Points Higher; Telecom and Power Stocks Witness Buying(Closing)

Indian share markets witnessed buying interest throughout the day today and ended on a positive note.

Related Views on News

WOCKHARDT Announces Quarterly Results (3QFY20); Net Profit Up 125.0% (Quarterly Result Update)

Jan 28, 2020 | Updated on Jan 28, 2020

For the quarter ended December 2019, WOCKHARDT has posted a net profit of Rs 192 m (up 125.0% YoY). Sales on the other hand came in at Rs 9 bn (down 16.9% YoY). Read on for a complete analysis of WOCKHARDT's quarterly results.

CADILA HEALTHCARE Announces Quarterly Results (2QFY20); Net Profit Down 79.3% (Quarterly Result Update)

Nov 15, 2019 | Updated on Nov 15, 2019

For the quarter ended September 2019, CADILA HEALTHCARE has posted a net profit of Rs 829 m (down 79.3% YoY). Sales on the other hand came in at Rs 34 bn (up 13.7% YoY). Read on for a complete analysis of CADILA HEALTHCARE's quarterly results.

WOCKHARDT Announces Quarterly Results (1QFY20); Net Profit Up 57.2% (Quarterly Result Update)

Aug 28, 2019 | Updated on Aug 28, 2019

For the quarter ended June 2019, WOCKHARDT has posted a net profit of Rs 369 m (up 57.2% YoY). Sales on the other hand came in at Rs 9 bn (down 14.3% YoY). Read on for a complete analysis of WOCKHARDT's quarterly results.

CADILA HEALTHCARE Announces Quarterly Results (1QFY20); Net Profit Down 28.9% (Quarterly Result Update)

Aug 13, 2019 | Updated on Aug 13, 2019

For the quarter ended June 2019, CADILA HEALTHCARE has posted a net profit of Rs 3 bn (down 28.9% YoY). Sales on the other hand came in at Rs 35 bn (up 20.8% YoY). Read on for a complete analysis of CADILA HEALTHCARE's quarterly results.

CADILA HEALTHCARE Announces Quarterly Results (4QFY19); Net Profit Down 21.0% (Quarterly Result Update)

May 30, 2019 | Updated on May 30, 2019

For the quarter ended March 2019, CADILA HEALTHCARE has posted a net profit of Rs 5 bn (down 21.0% YoY). Sales on the other hand came in at Rs 37 bn (up 14.8% YoY). Read on for a complete analysis of CADILA HEALTHCARE's quarterly results.

More Views on News

Most Popular

Be Prepared to Profit from the Coming Crash in Oil Prices(Fast Profits Daily)

Jun 25, 2020

The stability in crude oil prices will not last much longer. Be ready to make fast profits when the time comes to short crude.

How to Find the Best Stocks for Day Trading - 1(Fast Profits Daily)

Jul 2, 2020

In the first of two videos, I'll show you how to identify the best stocks for intraday trading.

Tata Motors Tripled in 18 Months but You Can Do Even Better. Here's How...(Profit Hunter)

Jun 24, 2020

Rahul is ready for a repeat of his famous 2008 Tata Motors call.

This Ratio Says Smallcaps Are Your Best Bet to Ride the Post Covid Market Rebound(Profit Hunter)

Jun 23, 2020

Here's why I believe that post Covid rebound in smallcaps will be much sharper than largecaps.

More

India's #1 Trader
Reveals His Secrets

The Secret to Increasing Your Trading Profits Today
Get this Special Report, The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

WOCKHARDT SHARE PRICE


Jul 3, 2020 (Close)

TRACK WOCKHARDT

  • Track your investment in WOCKHARDT with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

WOCKHARDT 8-QTR ANALYSIS

COMPARE WOCKHARDT WITH

MARKET STATS